Diagnostic imaging contrast agents with extended blood retention
US6676929B2 · kind B2 · utility
10Cited by
44References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2001 |
| Grant date | Jan 13, 2004 |
| Priority date | — |
| Expiry date | Apr 13, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B6/507
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.